Benitec Biopharma
BNTC
BNTC
21 hedge funds and large institutions have $1.55M invested in Benitec Biopharma in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
39% less capital invested
Capital invested by funds: $2.54M → $1.55M (-$991K)
89% less call options, than puts
Call options by funds: $1K | Put options by funds: $9K
Holders
21
Holding in Top 10
–
Calls
$1K
Puts
$9K
Top Buyers
| 1 | +$90K | |
| 2 | +$62K | |
| 3 | +$58K | |
| 4 |
VF
Virtu Financial
New York
|
+$55K |
| 5 |
Millennium Management
New York
|
+$29K |
Top Sellers
| 1 | -$87K | |
| 2 | -$46K | |
| 3 | -$1K | |
| 4 |
Bank of New York Mellon
New York
|
-$117 |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$57 |